Announcements Trials

Browse Landscape

Sponsor

Conditions

Myelodysplastic Syndromes 3 Recurrence 1 Primary Myelofibrosis 1 Oligodendroglioma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Gliosarcoma 1 Glioblastoma 1 Ependymoma 1 Brain Stem Neoplasms 1 Astrocytoma 1

Interventions

Trastuzumab 243 Paclitaxel 193 Cyclophosphamide 158 Docetaxel 134 Letrozole 113 Capecitabine 113 Fulvestrant 106 Doxorubicin 103 Bevacizumab 87 Carboplatin 81 exemestane 80 Anastrozole 79 Lapatinib 70 Tamoxifen 69 Albumin-Bound Paclitaxel 57 palbociclib 54 pertuzumab 53 Taxes 51 Gemcitabine 50 Radiotherapy 46 eribulin 43 pembrolizumab 41 Everolimus 41 Ado-Trastuzumab Emtansine 41 Vinorelbine 38 130-nm albumin-bound paclitaxel 35 ixabepilone 32 Epirubicin 28 pegfilgrastim 25 liposomal doxorubicin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Breast Neoplasms × GRN163L peptide × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡